Sheng, X., Jiang, S., Guo, H., Hu, B., Dong, H., Shi, B., Zhang, P., Yao, X., Yang, T., Huang, H., Cao, M., Dong, J., Wang, P., Wang, S., Guo, J. (2026). Bulumtatug fuvedotin (BFv; 9MW2821) plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (la/mUC): Follow-up results from a phase 1b/2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4518